These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Specific phobias in youth: a randomized controlled trial comparing one-session treatment to a parent-augmented one-session treatment.
    Author: Ollendick TH, Halldorsdottir T, Fraire MG, Austin KE, Noguchi RJ, Lewis KM, Jarrett MA, Cunningham NR, Canavera K, Allen KB, Whitmore MJ.
    Journal: Behav Ther; 2015 Mar; 46(2):141-55. PubMed ID: 25645164.
    Abstract:
    OBJECTIVE: Examine the efficacy of a parent-augmented One-Session Treatment (A-OST) in treating specific phobias (SP) in youth by comparing this novel treatment to child-focused OST, a well-established treatment. METHOD: A total of 97 youth (ages 6-15, 51.5% female, 84.5% White) who fulfilled diagnostic criteria for SP were randomized to either A-OST or OST. SPs were assessed with semistructured diagnostic interviews, clinician improvement ratings, and parent and child improvement ratings. In addition, measures of treatment satisfaction and parental self-efficacy were obtained. Blind assessments were completed pretreatment, posttreatment, and 1month and 6months following treatment. Analyses were undertaken using mixed models. In addition, gender, age, internalizing/externalizing problems, parent overprotection, and parent anxiety were examined as potential predictors and moderators of treatment outcome. RESULTS: Both treatment conditions produced similar outcomes with approximately 50% of youth in both treatments diagnosis free and judged to be much or very much improved at posttreatment and 1-month follow-up. At 6-month follow-up, however, the treatments diverged with OST resulting in marginally superior outcomes to A-OST, contrary to predictions. Only age of child predicted treatment outcome across the two treatments (older children did better); unexpectedly, none of the variables moderated treatment outcomes. CONCLUSIONS: Parent augmentation of OST produced no appreciable gains in treatment outcomes. Directions for future research are highlighted.
    [Abstract] [Full Text] [Related] [New Search]